News


All News

Nonsurgical browlift

In order to avoid the complications that can present from a surgical eyebrow lift, a study was conducted to test a nonsurgical, noninvasive eyebrow lift method.

BOTOX and Prostate

Botulinum toxin injected into the prostate reduced symptoms of benign prostatic hyperplasia (BPH) and prostate-specific antigen (PSA) levels and was well tolerated, according to the results of a randomized, placebo-controlled, preliminary trial (Urology 2003; 62:259-265).

Varicose Vein TX

VNUS Medical Technologies announced results of a peer-reviewed, multi-center randomized trial comparing recovery rates and quality of life between patients treated with conventional varicose vein stripping surgery and radiofrequency vein ablation (Closure procedure).

Powder helps scabbing

An scientist's accident has led to the development of a blood-clotting powder that works on contact and reportedly is being sold at CVS and Walgreens.

RADIOTHERAPY GRANT

AlphaMed Inc. announced that it received a $500,000 two-year STTR Phase II grant award from the National Cancer Institute to further develop a targeted radiotherapy for metastatic melanoma.

LImits of cetirizine

The use of antihistamine cetirizine during the first six weeks of nevirapine-containing antiretroviral treatment does not protect against nevirapine-associated cutaneous reactions, according to the results of a controlled study.

APMA SEAL OF APPROVAL

Upsher-Smith Laboratories Inc.'s Amlactin has been awarded the American Podiatric Medical Association (APMA) Seal of Approval, which recognizes products that are beneficial to foot health and of significant value when used in a consistently applied program of daily foot care and regular professional treatment.

ENBREL Indication Expanded

The FDA approved an expanded indication for Enbrel (etanercept) to inhibit the structural damage of active arthritis in patients with psoriatic arthritis, reported Amgen Inc. and Wyeth Pharmaceuticals.

MRSA Attacking Athletes

Methicillin-resistant staphylococcus aureus is hitting U.S. athletes hard in the form of soft-tissue and skin infections, according to a report from the Centers for Disease Control and Infection.

Herpes Study

According to a study of 36 primary care offices in relatively affluent suburban areas of six U.S. cities, one-fourth of people (25.5 percent) tested positive for the virus that causes genital herpes.

LEISHMANIASIS DRUG

AEterna Laboratories reported recently the results of a phase III trial evaluating its drug Impavido (miltefosine) for the treatment of cutaneous leishmaniasis, showing that patients taking Impavido had a 220-percent better cure rate compared with those in a placebo group.

Seborrheic Dermatitis

A randomized, placebo-controlled, double-blind clinical study with metronidazole in patients with mild to moderate seborrheic dermatitis found the drug seemed to lack effectiveness.

Disease Database

Officials in Duchess County, N.Y., introduced a medical database of infectious diseases, skin conditions, and drug information to help physicians and nurses make diagnoses based on visual information, according to reports.

As our overhead costs continue to increase while reimbursements decrease, physicians are motivated to find novel ways to reduce our fixed overhead costs. Nearly every practice has 15 percent of "fat" that has to be cut. Just a few cost-saving strategies will reduce thousands of dollars of overhead, and one of these strategies is to implement an electronic system of archiving medical records.

As professionals with many physician clients, we routinely are asked by physicians throughout the country to answer questions on a variety of topics. However, in our combined experiences, we have never been as inundated with calls as we have in the last year regarding the malpractice insurance situation. Doctors from all specialties and from all regions of the country have called us looking for ways to reduce their malpractice premiums or to find alternatives to their traditional carriers.

Softer Implants

San Francisco - As facial implants come of age, aging faces look even younger. UltraSoft implants are part of the next generation of ePTFE facial implants designed to be softer, with a wider diameter than their predecessor, the SoftForm implant. Manufactured by Tissue Technologies Inc., San Francisco, the permanent facial implants offer dermatologic surgeons an alternative to injectable or temporary fillers for nasolabial folds or lip augmentation that Nicholas Lowe, M.D., FRCP, believes is safer and more effective.

Mixed Reviews

Hermosa Beach, Calif. - Though not yet FDA-approved for use in the United States, Reviderm Intra is a hyaluronic gel filler with a shelf life that already may have passed, according to Gail Humble, M.D., medical director of Blue Pacific Aesthetic Medical Group in Hermosa Beach, Calif.

Coming Soon

San Francisco - The FDA has its eye on New-Fill (Dermik Laboratories), a polylactic acid filler that experts predict could become a popular treatment for moderate to deep wrinkles and volume loss.

Leading sources suggest that cosmetic surgeons should carefully monitor the psychological condition and ambitions of existing and potential cosmetic patients despite a recent study finding that aesthetic procedures significantly improve a patient's quality of life.

Melanoma Fighter

Chicago - Arginine deiminase, an amino acid degrading enzyme, is safe and has anti-tumor activity in phase I and II investigations of metastatic melanoma, according to Theodore Logan, M.D.

Chicago - There has been no good explanation as to why people who know that too much sun is not healthy continue to sunbathe or go to tanning salons. Now, for the first time, University of Texas researchers have shown that the act of suntanning shares characteristics of other substance-dependent disorders.

San Francisco - Syndromic hemangiomas are almost always segmental hemangiomas, associated with a constellation of birth defects probably arising from mutations affecting a developmental field, according to Ilona J. Frieden, M.D., clinical professor of dermatology and pediatrics, UCSF School of Medicine.

San Francisco - A baseline examination followed by yearly screening for retinopathy is probably adequate for patients taking chronic antimalarial therapy, Stephen E. Wolverton, M.D., said.

San Francisco - A multidisciplinary approach is best in management of problematic hemangiomas, often requiring close interaction with pediatricians, surgical teams, ophthalmologists, neurologists, radiologists, and psychologists, Julie Powell, M.D., said.

High Intensity

San Francisco - UVB-emitting lasers and light sources provide safe, convenient, and effective phototherapy for patients with localized psoriasis, vitiligo, and leukoderma, Christine A. Dierickx, M.D., said.

Vitiligo Treatment Advances

San Francisco - Treatment of vitiligo has advanced significantly in recent years with the use of topical immunomodulators and newer forms of phototherapy, Pearl F. Grimes, M.D., said.

San Francisco - Oral terbinafine (Lamisil) is the most cost-effective treatment for toenail onychomycosis as compared to other available agents, according to the results of an economic evaluation.

More Manageable

San Francisco - New topical and systemic treatments, and new uses for existing ones, are making several photodermatosis conditions more manageable, according to John L.M. Hawk, M.D.